Activation of the Ral and Phosphatidylinositol 3′ Kinase Signaling Pathways by the Ras-Related Protein TC21

ABSTRACT TC21 is a member of the Ras superfamily of small GTP-binding proteins that, like Ras, has been implicated in the regulation of growth-stimulating pathways. We have previously identified the Raf/mitogen-activated protein kinase pathway as a direct TC21 effector pathway required for TC21-induced transformation (M. Rosário, H. F. Paterson, and C. J. Marshall, EMBO J. 18:1270–1279, 1999). In this study we have identified two further effector pathways for TC21, which contribute to TC21-stimulated transformation: the phosphatidylinositol 3′ kinase (PI-3K) and Ral signaling pathways. Expression of constitutively active TC21 leads to the activation of Ral A and the PI-3K-dependent activation of Akt/protein kinase B. Strong activation of the PI-3K/Akt pathway is seen even with very low levels of TC21 expression, suggesting that TC21 may be a key small GTPase-regulator of PI-3K. TC21-induced alterations in cellular morphology in NIH 3T3 and PC12 cells are also PI-3K dependent. On the other hand, activation of the Ral pathway by TC21 is required for TC21-stimulated DNA synthesis but not transformed morphology. We show that inhibition of Ral signaling blocks DNA synthesis in human tumor cell lines containing activating mutations in TC21, demonstrating for the first time that this pathway is required for the proliferation of human tumor cells. Finally, we provide mechanisms for the activation of these pathways, namely, the direct in vivo interaction of TC21 with guanine nucleotide exchange factors for Ral, resulting in their translocation to the plasma membrane, and the direct interaction of TC21 with PI-3K. In both cases, the effector domain region of TC21 is required since point mutations in this region can interfere with activation of downstream signaling.

[1]  A. Kimmelman,et al.  R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells , 2000, Oncogene.

[2]  Christian Ried,et al.  Structural insights into phosphoinositide 3-kinase catalysis and signalling , 1999, Nature.

[3]  P. Crespo,et al.  Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins , 1999, Oncogene.

[4]  C. Der,et al.  M-Ras/R-Ras3, a Transforming Ras Protein Regulated by Sos1, GRF1, and p120 Ras GTPase-activating Protein, Interacts with the Putative Ras Effector AF6* , 1999, The Journal of Biological Chemistry.

[5]  J. Downward,et al.  Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression* , 1999, The Journal of Biological Chemistry.

[6]  Julian Downward,et al.  Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction , 1999, Current Biology.

[7]  S. Oldham,et al.  TC21 and Ras share indistinguishable transforming and differentiating activities , 1999, Oncogene.

[8]  H. Paterson,et al.  Activation of the Raf/MAP kinase cascade by the Ras‐related protein TC21 is required for the TC21‐mediated transformation of NIH 3T3 cells , 1999, The EMBO journal.

[9]  K. Barker,et al.  Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. , 1998, British Journal of Cancer.

[10]  M. Mann,et al.  Cell cycle progression: new therapeutic target for vascular proliferative disease. , 1998, Circulation.

[11]  R. Wolthuis,et al.  Activation of the Small GTPase Ral in Platelets , 1998, Molecular and Cellular Biology.

[12]  Y. Matsuura,et al.  Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator , 1997, Oncogene.

[13]  B. van der Burg,et al.  Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[14]  A. Kimmelman,et al.  Identi ® cation and characterization of R-ras 3 : a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution , 1997 .

[15]  R. Wolthuis,et al.  Stimulation of gene induction and cell growth by the Ras effector Rlf , 1997, The EMBO journal.

[16]  J. Bos Ras-like GTPases. , 1997, Biochimica et biophysica acta.

[17]  J. Downward,et al.  Interaction of Ras with phosphoinositide 3-kinase gamma. , 1997, The Biochemical journal.

[18]  Asim Khwaja,et al.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.

[19]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[20]  M. White,et al.  RalGDS Functions in Ras- and cAMP-mediated Growth Stimulation* , 1997, The Journal of Biological Chemistry.

[21]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[22]  P. Warne,et al.  R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways , 1997, Current Biology.

[23]  P. Tsichlis,et al.  Akt Is a Direct Target of the Phosphatidylinositol 3-Kinase , 1996, The Journal of Biological Chemistry.

[24]  C. Nobes,et al.  Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.

[25]  Y. Matsuura,et al.  Post-translational Modifications of Ras and Ral Are Important for the Action of Ral GDP Dissociation Stimulator* , 1996, The Journal of Biological Chemistry.

[26]  L. J. van 't Veer,et al.  RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. , 1996, Oncogene.

[27]  M. Wigler,et al.  A Role for the Ral Guanine Nucleotide Dissociation Stimulator in Mediating Ras-induced Transformation* , 1996, The Journal of Biological Chemistry.

[28]  M. Wigler,et al.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.

[29]  J. Downward,et al.  Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation. , 1996, The EMBO journal.

[30]  Gudrun Horn,et al.  Differential Interaction of the Ras Family GTP-binding Proteins H-Ras, Rap1A, and R-Ras with the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor , 1996, The Journal of Biological Chemistry.

[31]  P. Hawkins,et al.  Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase. , 1996, Journal of cell science.

[32]  M. Barbacid,et al.  The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor. , 1996, Oncogene.

[33]  T. Urano,et al.  Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. , 1996, The EMBO journal.

[34]  C. Der,et al.  Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. , 1996, Oncogene.

[35]  S. Aaronson,et al.  A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. , 1995, Oncogene.

[36]  M. Barbacid,et al.  Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation. , 1995, Oncogene.

[37]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[38]  M. Wigler,et al.  Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.

[39]  P. Hawkins,et al.  Activation of the small GTP-binding proteins rho and rac by growth factor receptors. , 1995, Journal of cell science.

[40]  J. Bischoff,et al.  Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Der,et al.  R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. , 1994, Oncogene.

[42]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[43]  S. Aaronson,et al.  A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[45]  P. D’Eustachio,et al.  Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation , 1994, Molecular and cellular biology.

[46]  F. Grigorescu,et al.  Involvement of phosphoinositide 3‐kinase in insulin‐ or IGF‐1‐induced membrane ruffling. , 1994, The EMBO journal.

[47]  M. Kasuga,et al.  Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling , 1994, Current Biology.

[48]  A. Hall,et al.  R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. , 1994, Oncogene.

[49]  B. Dutrillaux,et al.  Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. , 1990, British Journal of Cancer.

[50]  P. D’Eustachio,et al.  Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line , 1990, Molecular and cellular biology.

[51]  L. Greene,et al.  Growth cone configuration and advance: a time-lapse study using video- enhanced differential interference contrast microscopy , 1988, Journal of Neuroscience.

[52]  D. Stacey,et al.  Cellular ras activity and tumor cell proliferation. , 1987, Experimental cell research.

[53]  D. Burstein,et al.  Activated N‐ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells , 1986, Journal of cellular physiology.

[54]  A. Kimmelman,et al.  R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells , 2000, Oncogene.

[55]  Christian Ried,et al.  Structural insights into phosphoinositide 3-kinase catalysis and signalling , 1999, Nature.

[56]  P. Crespo,et al.  Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins , 1999, Oncogene.

[57]  C. Der,et al.  M-Ras/R-Ras3, a Transforming Ras Protein Regulated by Sos1, GRF1, and p120 Ras GTPase-activating Protein, Interacts with the Putative Ras Effector AF6* , 1999, The Journal of Biological Chemistry.

[58]  J. Downward,et al.  Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression* , 1999, The Journal of Biological Chemistry.

[59]  Julian Downward,et al.  Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction , 1999, Current Biology.

[60]  S. Oldham,et al.  TC21 and Ras share indistinguishable transforming and differentiating activities , 1999, Oncogene.

[61]  H. Paterson,et al.  Activation of the Raf/MAP kinase cascade by the Ras‐related protein TC21 is required for the TC21‐mediated transformation of NIH 3T3 cells , 1999, The EMBO journal.

[62]  K. Barker,et al.  Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. , 1998, British Journal of Cancer.

[63]  R. Wolthuis,et al.  Activation of the Small GTPase Ral in Platelets , 1998, Molecular and Cellular Biology.

[64]  Y. Matsuura,et al.  Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator , 1997, Oncogene.

[65]  A. Kimmelman,et al.  Identi ® cation and characterization of R-ras 3 : a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution , 1997 .

[66]  R. Wolthuis,et al.  Stimulation of gene induction and cell growth by the Ras effector Rlf , 1997, The EMBO journal.

[67]  J. Bos Ras-like GTPases. , 1997, Biochimica et biophysica acta.

[68]  J. Downward,et al.  Interaction of Ras with phosphoinositide 3-kinase gamma. , 1997, The Biochemical journal.

[69]  Asim Khwaja,et al.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.

[70]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[71]  M. White,et al.  RalGDS Functions in Ras- and cAMP-mediated Growth Stimulation* , 1997, The Journal of Biological Chemistry.

[72]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[73]  P. Warne,et al.  R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways , 1997, Current Biology.

[74]  P. Tsichlis,et al.  Akt Is a Direct Target of the Phosphatidylinositol 3-Kinase , 1996, The Journal of Biological Chemistry.

[75]  C. Nobes,et al.  Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.

[76]  Y. Matsuura,et al.  Post-translational Modifications of Ras and Ral Are Important for the Action of Ral GDP Dissociation Stimulator* , 1996, The Journal of Biological Chemistry.

[77]  L. J. van 't Veer,et al.  RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. , 1996, Oncogene.

[78]  M. Wigler,et al.  A Role for the Ral Guanine Nucleotide Dissociation Stimulator in Mediating Ras-induced Transformation* , 1996, The Journal of Biological Chemistry.

[79]  M. Wigler,et al.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.

[80]  J. Downward,et al.  Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation. , 1996, The EMBO journal.

[81]  Gudrun Horn,et al.  Differential Interaction of the Ras Family GTP-binding Proteins H-Ras, Rap1A, and R-Ras with the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor , 1996, The Journal of Biological Chemistry.

[82]  M. Barbacid,et al.  The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor. , 1996, Oncogene.

[83]  T. Urano,et al.  Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. , 1996, The EMBO journal.

[84]  P. Hawkins,et al.  Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase. , 1996, Journal of cell science.

[85]  C. Der,et al.  Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. , 1996, Oncogene.

[86]  S. Aaronson,et al.  A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. , 1995, Oncogene.

[87]  M. Barbacid,et al.  Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation. , 1995, Oncogene.

[88]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[89]  M. Wigler,et al.  Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.

[90]  P. Hawkins,et al.  Activation of the small GTP-binding proteins rho and rac by growth factor receptors. , 1995, Journal of cell science.

[91]  J. Bischoff,et al.  Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[92]  C. Der,et al.  R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. , 1994, Oncogene.

[93]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[94]  S. Aaronson,et al.  A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[95]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[96]  P. D’Eustachio,et al.  Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation , 1994, Molecular and cellular biology.

[97]  F. Grigorescu,et al.  Involvement of phosphoinositide 3‐kinase in insulin‐ or IGF‐1‐induced membrane ruffling. , 1994, The EMBO journal.

[98]  M. Kasuga,et al.  Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling , 1994, Current Biology.

[99]  A. Hall,et al.  R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. , 1994, Oncogene.

[100]  B. Dutrillaux,et al.  Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. , 1990, British Journal of Cancer.

[101]  P. D’Eustachio,et al.  Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line , 1990, Molecular and cellular biology.

[102]  L. Greene,et al.  Growth cone configuration and advance: a time-lapse study using video- enhanced differential interference contrast microscopy , 1988, Journal of Neuroscience.

[103]  D. Stacey,et al.  Cellular ras activity and tumor cell proliferation. , 1987, Experimental cell research.

[104]  D. Burstein,et al.  Activated N‐ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells , 1986, Journal of cellular physiology.